Skip to main content
. 2018 May 18;97(9):1701–1706. doi: 10.1007/s00277-018-3367-9

Table 1.

Patient demographics and baseline characteristics

Characteristic Overall (N = 158) No Infections (N = 120) Infections (N = 38)
Age (year) 42 ± 16 42 ± 16 42 ± 16
Sex (m/f) 51/107 37/83 14/24
Hemoglobin value (mg/dL) at t = 0 123.2 ± 28.6 122.1 ± 30.8 126.8 ± 20.1
Leucocyte count (× 109/L) at t = 0 7.7 ± 3.4 7.2 ± 3.2 9.1 ± 3.6*
Platelet count (× 109/L) at t = 0 13.4 ± 12.2 13.8 ± 12.8 11.8 ± 10.4
Hemoglobin value (mg/dL) at t = 1 month 125.5 ± 32.2 124.0 ± 23.9 130.4 ± 50.3
Leucocyte count (× 109/L) at t = 1 month 11.0 ± 7.9 11.2 ± 7.8 10.5 ± 8.2
Platelet count (× 109/L) at t = 1 month 87.7 ± 78.7 107.4 ± 79.7 25.4 ± 24.3*
Bleeding score 3.9 ± 3.4 3.8 ± 3.5 4.1 ± 3,2
Duration hospital stay (days) 10.9 ± 6.5 9.8 ± 5.2 14.0 ± 8.7*
Treatment (dexamethasone/prednisone) 118/40 87/33 31/7
Antibodies
 None 46 35 11
 GPIb-IX 13 11 2
 GPIIbIIIa 15 7 8
 Both 18 16 2
 Unknown 66 51 15
Type of infection
 Viral 11
 Bacterial 27
Time of infection (day) 5.7 ± 5.1
Platelet transfusion
 Number of patients transfused 91 (57.6%) 62 (51.7%) 29 (76.3%)
 Total amount of units 150 91 59
 Median amount of units 1 1 1
 Mean 1.0 0.8 1.6*

Mean values for age, platelet count, leucocyte count, hemoglobin values, bleeding score, hospital stay, and time of infection ± standard deviations are shown. Bleeding score was calculated by adding the points relevant to various clinical bleeding signs as described by Wei et al. [11]

*p < 0.01